GEN Exclusives

More »

GEN News Highlights

More »
Oct 26, 2006

Viropro Will Use NRC-BRI’s Protein Expression Systems

  • Viropro will use the National Research Council-Biotechnology Research Institute’s (NRC-BRI) inducible expression systems, under an agreement with them.

    These expression systems are integrated into CHO cells, which are used by Viropro for its transfer of technology. They are designed to control and maximize the expression of proteins thus allowing high production yields, as well as time and cost savings, according to the company.

    Viropro has also obtained a worldwide, exclusive licence for the production of the recombinant human interferon-β.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »